BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21483822)

  • 61. Lack of association of two common polymorphisms rs2910164 and rs11614913 with susceptibility to hepatocellular carcinoma: a meta-analysis.
    Wang Z; Cao Y; Jiang C; Yang G; Wu J; Ding Y
    PLoS One; 2012; 7(6):e40039. PubMed ID: 22768213
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A variant in microRNA-196a2 is not associated with susceptibility to and progression of colorectal cancer in Chinese.
    Chen H; Sun LY; Chen LL; Zheng HQ; Zhang QF
    Intern Med J; 2012 Jun; 42(6):e115-9. PubMed ID: 21241442
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study.
    Akkız H; Bayram S; Bekar A; Akgöllü E; Ulger Y
    J Viral Hepat; 2011 Jul; 18(7):e399-407. PubMed ID: 21692953
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Analysis of association of genetic polymorphisms of microRNAs with ischemic stroke].
    Zhu H; Zhang H; Bao L; Dai M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Apr; 34(2):261-265. PubMed ID: 28397233
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A passenger strand variant in miR-196a2 contributes to asthma severity in children and adolescents: A preliminary study.
    Hussein MH; Toraih EA; Aly NM; Riad E; Fawzy MS
    Biochem Cell Biol; 2016 Aug; 94(4):347-57. PubMed ID: 27487239
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Two functional polymorphisms in microRNAs and lung cancer risk: a meta-analysis.
    Wang G; Wang W; Gao W; Lv J; Fang J
    Tumour Biol; 2014 Mar; 35(3):2693-9. PubMed ID: 24254303
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Association of a LSP1 gene rs3817198T>C polymorphism with breast cancer risk: evidence from 33,920 cases and 35,671 controls.
    Chen MB; Li C; Shen WX; Guo YJ; Shen W; Lu PH
    Mol Biol Rep; 2011 Oct; 38(7):4687-95. PubMed ID: 21127985
    [TBL] [Abstract][Full Text] [Related]  

  • 68. MicroRNA-196a2 Biomarker and Targetome Network Analysis in Solid Tumors.
    Toraih EA; Fawzy MS; Mohammed EA; Hussein MH; El-Labban MM
    Mol Diagn Ther; 2016 Dec; 20(6):559-577. PubMed ID: 27342110
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Contribution of microRNA-149, microRNA-146a, and microRNA-196a2 SNPs in colorectal cancer risk and clinicopathological features in Tunisia.
    Chayeb V; Mahjoub S; Zitouni H; Jrah-Harzallah H; Zouari K; Letaief R; Mahjoub T
    Gene; 2018 Aug; 666():100-107. PubMed ID: 29715515
    [TBL] [Abstract][Full Text] [Related]  

  • 70. FASL rs763110 polymorphism contributes to cancer risk: an updated meta-analysis involving 43,295 subjects.
    Xu L; Zhou X; Jiang F; Qiu MT; Zhang Z; Yin R; Xu L
    PLoS One; 2013; 8(9):e74543. PubMed ID: 24086353
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The miRNA 196a2 rs11614913 variant has prognostic impact on Turkish patients with multiple myeloma.
    Kirik MP; Pehlivan M; Nursal AF; Oyaci Y; Pehlivan S; Serin I
    BMC Res Notes; 2020 Nov; 13(1):545. PubMed ID: 33228759
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Association of Hsa-miR-23a rs3745453 variation with prostate cancer risk among Chinese Han population: A case-control study.
    Zhang M; Wang Y; Wang C; You Z; Chen S; Kong Q; Xu B; Liu C; Chen M
    Medicine (Baltimore); 2019 Dec; 98(52):e18523. PubMed ID: 31876746
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A functional polymorphism in miRNA-196a2 is associated with colorectal cancer risk in a Chinese population.
    Zhu L; Chu H; Gu D; Ma L; Shi D; Zhong D; Tong N; Zhang Z; Wang M
    DNA Cell Biol; 2012 Mar; 31(3):350-4. PubMed ID: 21815818
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The association between hsa-miR-499 T>C polymorphism and cancer risk: a meta-analysis.
    Wang L; Qian S; Zhi H; Zhang Y; Wang B; Lu Z
    Gene; 2012 Oct; 508(1):9-14. PubMed ID: 22903035
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Association between hsa-miR-34b/c rs4938723 T > C promoter polymorphism and cancer risk: a meta-analysis based on 6,036 cases and 6,204 controls.
    Tao T; Chen S; Xu B; Liu C; Wang Y; Huang Y; Chen M
    Chin J Cancer Res; 2014 Jun; 26(3):315-22. PubMed ID: 25035659
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Lack of association between miR-149 C>T polymorphism and cancer susceptibility: a meta-analysis based on 4,677 cases and 4,830 controls.
    Zhang J; Liu YF; Gan Y
    Mol Biol Rep; 2012 Sep; 39(9):8749-53. PubMed ID: 22714913
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Association of Fas -1377 G/A polymorphism with susceptibility to cancer.
    Geng P; Li J; Ou J; Xie G; Wang N; Xiang L; Sa R; Liu C; Li H; Liang H
    PLoS One; 2014; 9(2):e88748. PubMed ID: 24558420
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The -842G/C polymorphisms of PIN1 contributes to cancer risk: a meta-analysis of 10 case-control studies.
    Xu HR; Xu ZF; Sun YL; Han JJ; Li ZJ
    PLoS One; 2013; 8(8):e71516. PubMed ID: 24013949
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Meta-analyses of the relationship between five CXCL8 gene polymorphisms and overall cancer risk, and a case-control study of oral cancer.
    Peng J; Wang Y; Kuang D; Wang Y; Wu G; Li H; Li D; Cao H
    BMC Oral Health; 2024 May; 24(1):622. PubMed ID: 38807156
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    Zhong J; Liu J; Zheng Y; Xie X; He Q; Zhong W; Wu Q
    Per Med; 2021 Sep; 18(6):551-558. PubMed ID: 34761964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.